CREDO TECHNOLOGY GROUP HOLDI (CRDO)

KYG254571055 - Common Stock

28.765  +1.72 (+6.34%)

Fundamental Rating

5

CRDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. CRDO has a great financial health rating, but its profitability evaluates not so good. CRDO is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

CRDO had positive earnings in the past year.
CRDO had a positive operating cash flow in the past year.
CRDO had negative earnings in each of the past 5 years.
CRDO had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

CRDO has a worse Return On Assets (-4.06%) than 65.74% of its industry peers.
CRDO has a Return On Equity of -4.74%. This is in the lower half of the industry: CRDO underperforms 63.89% of its industry peers.
Industry RankSector Rank
ROA -4.06%
ROE -4.74%
ROIC N/A
ROA(3y)-4.92%
ROA(5y)-6.49%
ROE(3y)-5.55%
ROE(5y)-7.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CRDO has a Gross Margin of 62.47%. This is amongst the best in the industry. CRDO outperforms 86.11% of its industry peers.
In the last couple of years the Gross Margin of CRDO has declined.
The Profit Margin and Operating Margin are not available for CRDO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.74%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

CRDO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRDO has more shares outstanding than it did 1 year ago.
There is no outstanding debt for CRDO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CRDO has an Altman-Z score of 30.08. This indicates that CRDO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 30.08, CRDO belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
There is no outstanding debt for CRDO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 30.08
ROIC/WACCN/A
WACC12.58%

2.3 Liquidity

A Current Ratio of 7.81 indicates that CRDO has no problem at all paying its short term obligations.
CRDO has a Current ratio of 7.81. This is amongst the best in the industry. CRDO outperforms 90.74% of its industry peers.
A Quick Ratio of 7.36 indicates that CRDO has no problem at all paying its short term obligations.
CRDO's Quick ratio of 7.36 is amongst the best of the industry. CRDO outperforms 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 7.81
Quick Ratio 7.36

8

3. Growth

3.1 Past

CRDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4611686018427388928.00%, which is quite impressive.
CRDO shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.90%.
Measured over the past years, CRDO shows a very strong growth in Revenue. The Revenue has been growing by 48.69% on average per year.
EPS 1Y (TTM)4611686018427389000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%233.33%
Revenue 1Y (TTM)25.9%
Revenue growth 3Y48.69%
Revenue growth 5YN/A
Sales Q2Q%70.14%

3.2 Future

CRDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 130.70% yearly.
Based on estimates for the next years, CRDO will show a very strong growth in Revenue. The Revenue will grow by 48.83% on average per year.
EPS Next Y306.53%
EPS Next 2Y191.2%
EPS Next 3Y130.7%
EPS Next 5YN/A
Revenue Next Year64.65%
Revenue Next 2Y58.76%
Revenue Next 3Y48.83%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 179.78, CRDO can be considered very expensive at the moment.
CRDO's Price/Earnings is on the same level as the industry average.
CRDO is valuated expensively when we compare the Price/Earnings ratio to 30.45, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 37.69 indicates a quite expensive valuation of CRDO.
CRDO's Price/Forward Earnings is on the same level as the industry average.
CRDO is valuated expensively when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 179.78
Fwd PE 37.69

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CRDO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRDO's earnings are expected to grow with 130.70% in the coming years.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y191.2%
EPS Next 3Y130.7%

0

5. Dividend

5.1 Amount

CRDO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CREDO TECHNOLOGY GROUP HOLDI

NASDAQ:CRDO (9/19/2024, 11:24:05 AM)

28.765

+1.72 (+6.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.78B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 179.78
Fwd PE 37.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.06%
ROE -4.74%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 62.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 7.81
Quick Ratio 7.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)4611686018427389000%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y306.53%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.9%
Revenue growth 3Y48.69%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y